Skip to content
SHOP
  • Home
  • About
  • Science
  • Pipeline
  • News
  • Contact
  • Home
  • About
  • Science
  • Pipeline
  • News
  • Contact
SHOP

News

BioVinc Will Present New Data at the 2017 ASBMR Annual Meeting

September 2, 2017

BioVinc Receives an STTR Phase II Grant from the National Institutes of Health

September 1, 2017

BioVinc’s research has been selected as a Cover Story in the Journal of Medicinal Chemistry

March 23, 2017

BioVinc Receives an SBIR Phase II Grant from the National Institutes of Health

March 15, 2017
Previous Page1 Page2 Page3 Next

BioVinc (BV) has pioneered a groundbreaking skeletal-targeted therapy for life-threatening orthopedic infections and osteomyelitis. This innovation makes it possible to eradicate biofilms, including the previously untreatable MRSA on infected implants—offering new hope to prevent amputation and save lives.

Linkedin-in Youtube

BioVinc Data Room

We welcome investors to review our recent OsteoFloxacin™ data and trial results.

Request Access

LINKS

  • About Us
  • Our Science
  • Pipeline
  • News

CONTACT US

2265 E. Foothill Blvd.
Pasadena, CA 91107 USA

+1 (310) 730-5609

info@biovinc.com

©2026 BioVinc, LLC. All rights reserved.
  • Privacy Policy
  • Terms & Conditions
Biotech Website Design
stellar biotech design